Plain-English translation of NCT03334708 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →Researchers at Memorial Sloan Kettering Cancer Center are working to develop a simple blood test that could catch pancreatic cancer much earlier than current methods allow. By collecting blood samples from people with pancreatic cancer at different stages of their disease, as well as from people with other pancreatic conditions and healthy people, the researchers hope to identify special markers in the blood that signal cancer presence or progression.
Pancreatic cancer is often found late, when it's harder to treat. A blood-based test could help doctors catch the disease sooner and monitor whether treatment is working, which would give patients better chances for survival.
You likely qualify if…
You likely don't qualify if…
Your involvement depends on which group you join. If you have advanced pancreatic cancer being treated, you'll give blood samples before treatment starts, after your first round of chemotherapy, every 8–12 weeks during treatment, and when your disease progresses. If you have a benign pancreatic condition, you'll provide blood samples once or every 6–12 months for follow-up. Healthy volunteers give one blood sample. All samples are used to identify markers that could help diagnose and monitor pancreatic cancer.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States